These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 15088929)

  • 1. The Polypill and type 2 diabetes.
    Gale E
    Diabet Med; 2004 Jan; 21 Suppl 1():8-10. PubMed ID: 15088929
    [No Abstract]   [Full Text] [Related]  

  • 2. [The Polypill: between myths and reality in the treatment of type 2 diabetes mellitus].
    Ruiz J; Egli M
    Rev Med Suisse; 2006 May; 2(68):1480-2, 1484-5. PubMed ID: 16783994
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The combined use of aspirin, a statin, and blood pressure-lowering agents (polypill components) in clinical practice in patients with vascular diseases or type 2 diabetes mellitus.
    Lafeber M; Grobbee DE; Spiering W; van der Graaf Y; Bots ML; Visseren FL;
    Eur J Prev Cardiol; 2013 Oct; 20(5):771-8. PubMed ID: 22649123
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antihypertensive treatments for adults with type 2 diabetes.
    Majumdar SR
    BMJ; 2016 Feb; 352():i560. PubMed ID: 26867645
    [No Abstract]   [Full Text] [Related]  

  • 5. Answering the unanswered questions: ongoing trials of statins and antihypertensives in type 2 diabetes.
    Scott R
    Acta Diabetol; 2002 Jun; 39 Suppl 2():S46-51. PubMed ID: 12222628
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Latin American Consensus on the management of hypertension in the patient with diabetes and the metabolic syndrome.
    López-Jaramillo P; Barbosa E; Molina DI; Sanchez R; Diaz M; Camacho PA; Lanas F; Pasquel M; Accini JL; Ponte-Negretti CI; Alcocer L; Cobos L; Wyss F; Sebba-Barroso W; Coca A; Zanchetti A;
    J Hypertens; 2019 Jun; 37(6):1126-1147. PubMed ID: 30882601
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiovascular disease prevention using fixed dose pharmacotherapy in Iran: updated meta-analyses and mortality estimation.
    Sepanlou SG; Farzadfar F; Jafari E; Danaei G
    Arch Iran Med; 2012 Sep; 15(9):531-7. PubMed ID: 22924369
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Should we prescribe statin and aspirin for every diabetic patient? Is it time for a polypill?
    Wienbergen H; Senges J; Gitt AK
    Diabetes Care; 2008 Feb; 31 Suppl 2():S222-5. PubMed ID: 18227489
    [No Abstract]   [Full Text] [Related]  

  • 9. [Need of tight blood pressure control in type 2 diabetes. The intervention study ADVANCE gives clear information].
    Nilsson PM
    Lakartidningen; 2007 Oct 17-23; 104(42):3028-9. PubMed ID: 17985709
    [No Abstract]   [Full Text] [Related]  

  • 10. CCBs vs ACE inhibitors in patients with diabetes.
    Zamorski MA
    J Fam Pract; 1998 Jul; 47(1):12-3. PubMed ID: 9673598
    [No Abstract]   [Full Text] [Related]  

  • 11. Prevention of cardiovascular events in diabetes.
    Sigal R; Malcolm J; Meggison H
    Clin Evid; 2004 Jun; (11):777-806. PubMed ID: 15652037
    [No Abstract]   [Full Text] [Related]  

  • 12. Prevention of cardiovascular events in diabetes.
    Malcolm J; Meggison H; Sigal R
    Clin Evid; 2003 Dec; (10):690-714. PubMed ID: 15555116
    [No Abstract]   [Full Text] [Related]  

  • 13. Prevention of cardiovascular events in diabetes.
    Sigal R; Malcolm J; Arnaout A
    Clin Evid; 2006 Jun; (15):623-45. PubMed ID: 16973029
    [No Abstract]   [Full Text] [Related]  

  • 14. ACE inhibitors and antihypertensive treatment in diabetes: focus on microalbuminuria and macrovascular disease.
    Mogensen CE
    J Renin Angiotensin Aldosterone Syst; 2000 Sep; 1(3):234-9. PubMed ID: 11881030
    [No Abstract]   [Full Text] [Related]  

  • 15. "Polypill-aspostatinoprilololazide folate"--coprescription for at the risk Asian Indian in chronic non communicable diseases.
    Joshi SR
    J Assoc Physicians India; 2005 Mar; 53():175-8. PubMed ID: 15926597
    [No Abstract]   [Full Text] [Related]  

  • 16. Antihypertensive treatment and mortality in diabetic patients. What is the evidence?
    Sawicki PT; Heise T; Berger M
    Diabetologia; 1997 Jul; 40 Suppl 2():S134-7. PubMed ID: 9248721
    [No Abstract]   [Full Text] [Related]  

  • 17. Polypill eligibility and equivalent intake in a Swiss population-based study.
    Castioni J; Abolhassani N; Vollenweider P; Waeber G; Marques-Vidal P
    Sci Rep; 2021 Mar; 11(1):6880. PubMed ID: 33767231
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Step Ahead in Secondary Prevention of Cardiovascular Risk. Consensus Document on Clinical Use of the Polypill.
    González-Juanatey JR; Mostaza JM; Lobos JM; Abarca B; Llisterri JL
    Rev Esp Cardiol (Engl Ed); 2016 Jun; 69(6):547-50. PubMed ID: 27062678
    [No Abstract]   [Full Text] [Related]  

  • 19. [Towards new targets in the treatment of hypertension?].
    Faucon AL; Madjalian AM; Bobrie G; Amar L; Azizi M
    Med Sci (Paris); 2016 Oct; 32(10):861-866. PubMed ID: 27758750
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Blood pressure control in type 2 diabetes mellitus.
    Krantz MJ
    Ann Intern Med; 2004 Mar; 140(6):487; author reply 487-8. PubMed ID: 15023718
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.